BRAIN HEALTH TOGETHER: A LIVE-STREAMING GROUP-BASED DIGITAL PROGRAM
共同促进大脑健康:基于小组的直播数字节目
基本信息
- 批准号:10324919
- 负责人:
- 金额:$ 150.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-30 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeAgingAlzheimer&aposs disease related dementiaAmericanAwarenessBehavior TherapyBlood PressureBrainBusinessesCaregiversClinicalCognitiveControl GroupsDementiaDevelopmentDiabetes MellitusElderlyEmotionalEvidence based programExerciseGoalsHealthHomeHumanHypertensionImpaired cognitionInformal Social ControlInterventionLife StyleMaintenanceMediatingMental DepressionMissionMovementOutcomeParticipantPersonal SatisfactionPersonsPharmaceutical PreparationsPhasePhysical FunctionPositioning AttributeProcessPublic HealthQuality of lifeRandomizedRandomized Controlled TrialsReportingResearchResearch PersonnelResearch ProposalsRestRiskRisk FactorsRisk ReductionSmall Business Innovation Research GrantSocial isolationTechniquesTestingTrainingVulnerable PopulationsWomanWorkbasebrain healthcognitive benefitscognitive functioncomparison groupdaily functioningdementia riskdesigndiabetes managementdietary supplementsdigitalevidence baseexercise programexperiencefunctional MRI scangroup interventionimprovedimproved functioninginnovationlive streammild cognitive impairmentmindfulnessmodifiable riskphase 1 studyphysical inactivitypreventprogramssocialsocial engagementtrial comparingvirtual
项目摘要
Together Senior Health, Inc. (TOGETHER) is a woman-owned small business that is dedicated to helping
older adults with cognitive decline or Alzheimer’s disease and related dementias (ADRD) maintain quality of life
and independence by offering innovative, evidence-based, online, livestream, group programs. Our first
product on the TOGETHER audio/video platform is Moving TogetherTM—which combines movements to
support daily function with mindful body awareness exercises and social engagement and is designed for
people with mild ADRD and their caregivers who participate together from home. The primary goal of this
Phase II Small Business Innovation Research (SBIR) grant is to expand our product line by developing
and testing a comprehensive BRAIN HEALTH TOGETHER program for people living with mild cognitive
impairment (MCI). This goal represents a critically important next step for our company from both public
health and business perspectives. Older adults with MCI represent a large market with important unmet needs:
approximately 20% of older adults (>2.7 million Americans) are currently living with MCI, which places them at
increased risk of developing ADRD. There are no medications that can prevent development of ADRD in
people with MCI; however, there is growing evidence that behavioral interventions targeting modifiable
dementia risk factors—such as physical inactivity, social isolation, and depression—may help improve
cognitive function and could potentially delay dementia onset. Our preliminary results suggest that our product,
Moving Together is associated with significant improvements in cognitive function, physical function, social
isolation, and self-regulation as well as increased default mode network connectivity on pre/post resting state
functional magnetic resonance imaging (rs-fMRI) scans in people with MCI. We believe that these benefits
would be even greater if Moving Together were combined with a comprehensive brain health coaching
program. Therefore, our Specific Aims are to: 1) Work with our Scientific Advisory Board and use
humancentered design to develop evidence-based content for Brain Health Together, a 12-week, group-based,
livestreaming, digital program that will combine Moving Together with brain health coaching to address
modifiable dementia risk factors in people with MCI; 2) Perform a randomized, controlled trial to determine
whether the Brain Health Together program improves cognitive function in people with MCI over 12 weeks
compared to a Successful Aging comparison group; and 3) Determine whether weekly maintenance classes
help to sustain the effects of the Brain Health Together program over 12 weeks after the intervention. If we can
demonstrate that BRAIN HEALTH TOGETHER has immediate and sustained cognitive benefits in
people with MCI, it will position TOGETHER as a national leader in evidence-based programs to
improve quality of life and prevent decline in older adults with cognitive impairment.
共同的高级Health,Inc。(一起)是一家女性拥有的小型企业,致力于帮助
认知能力下降或阿尔茨海默氏病和相关痴呆症(ADRD)的老年人保持生活质量
和独立性,提供创新的,循证的,在线,直播,小组计划。我们的第一个
共同的音频/视频平台上的产品正在移动togethertm,将动作结合到
通过正念的身体意识练习和社交参与来支持日常功能,并专为
有轻度ADRD的人及其照顾者在家中一起参加。这个主要目标
第二阶段小型企业创新研究(SBIR)赠款是通过开发扩展我们的产品线
并针对患有轻度认知的人一起测试全面的大脑健康计划
损害(MCI)。这个目标代表了我们公司的下一步至关重要的下一步
健康和商业观点。 MCI的老年人代表着一个大型市场,有重要的未满足需求:
目前约有20%的老年人(> 270万美国人)生活在MCI中,这使他们处于
增加了ADRD的风险。没有药物可以阻止ADRD的发展
有MCI的人;但是,越来越多的证据表明,行为干预措施针对可修改
痴呆症危险因素(例如身体上的不活动,社会隔离和抑郁)可能有助于改善
认知功能,可能会延迟痴呆发作。我们的初步结果表明我们的产品,
一起移动与认知功能,身体机能,社会的显着改善有关
隔离和自我调节以及增加默认模式网络连接在预/静止状态下
MCI患者的功能磁共振成像(RS-FMRI)扫描。我们相信这些好处
如果将一起移动与全面的大脑健康指导结合在一起,将会更大
程序。因此,我们的具体目的是:1)与我们的科学咨询委员会合作并使用
Humantent的设计,共同开发基于证据的大脑健康内容,一个为基于小组的12周,
直播,数字程序,将与大脑健康教练一起移动以解决
MCI患者的可修改痴呆症危险因素; 2)执行随机对照试验以确定
大脑健康计划是否可以改善MCI患者的认知功能,超过12周
与成功的衰老比较组相比; 3)确定是否每周维护课程
干预后12周内,帮助维持大脑健康的影响。如果可以的话
证明大脑健康共同具有立即和持续的认知益处
具有MCI的人,它将在循证计划中将其定位为国家领导者
改善生活质量并防止认知障碍的老年人下降。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Deborah E. Barnes其他文献
VA Symposium: Links to Dementia
- DOI:
10.1016/j.jagp.2012.12.079 - 发表时间:
2013-03-01 - 期刊:
- 影响因子:
- 作者:
Marie A. DeWitt;Deborah E. Barnes;Mark E. Kunik;Sharon M. Gordon - 通讯作者:
Sharon M. Gordon
English- and Spanish-Speaking Vulnerable Older Adults Report Many Unique Barriers to Advance Care Planning (W215A)
- DOI:
10.1016/j.jpainsymman.2021.01.015 - 发表时间:
2021-03-01 - 期刊:
- 影响因子:
- 作者:
Linda H. Phung;Deborah E. Barnes;Aiesha M. Volow;Nikita R. Shirsat;Rebecca L. Sudore - 通讯作者:
Rebecca L. Sudore
Scientific quality of original research articles on environmental tobacco smoke
关于环境烟草烟雾的原创研究文章的科学质量
- DOI:
10.1136/tc.6.1.19 - 发表时间:
1997 - 期刊:
- 影响因子:5.2
- 作者:
Deborah E. Barnes;L. Bero - 通讯作者:
L. Bero
Lifestyle and health-related risk factors and risk of cognitive aging among older veterans
- DOI:
10.1016/j.jalz.2014.04.010 - 发表时间:
2014-06-01 - 期刊:
- 影响因子:
- 作者:
Kristine Yaffe;Tina D. Hoang;Amy L. Byers;Deborah E. Barnes;Karl E. Friedl - 通讯作者:
Karl E. Friedl
Deborah E. Barnes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Deborah E. Barnes', 18)}}的其他基金
A Novel Algorithm to Identify People with Undiagnosed Alzheimer's Disease and Related Dementias
一种识别未确诊阿尔茨海默病和相关痴呆症患者的新算法
- 批准号:
10696912 - 财政年份:2023
- 资助金额:
$ 150.5万 - 项目类别:
BRAIN HEALTH TOGETHER: A LIVE-STREAMING GROUP-BASED DIGITAL PROGRAM
共同促进大脑健康:基于小组的直播数字节目
- 批准号:
10747235 - 财政年份:2021
- 资助金额:
$ 150.5万 - 项目类别:
BRAIN HEALTH TOGETHER: A LIVE-STREAMING GROUP-BASED DIGITAL PROGRAM
共同促进大脑健康:基于小组的直播数字节目
- 批准号:
10493302 - 财政年份:2021
- 资助金额:
$ 150.5万 - 项目类别:
Identifying and supporting patients with undiagnosed dementia using the EHR Risk of Alzheimer's and Dementia Assessment Rule (eRADAR): a pilot clinical trial
使用 EHR 阿尔茨海默氏症和痴呆症风险评估规则 (eRADAR) 识别和支持未确诊的痴呆症患者:一项试点临床试验
- 批准号:
10409614 - 财政年份:2020
- 资助金额:
$ 150.5万 - 项目类别:
EXTENDING INDEPENDENCE AND QUALITY OF LIFE FOR PEOPLE WITH ALZHEIMER'S DISEASE OR DEMENTIA THROUGH TELEHEALTH PROGRAM DELIVERY
通过远程医疗计划的实施,提高阿尔茨海默病或痴呆症患者的独立性和生活质量
- 批准号:
10204865 - 财政年份:2020
- 资助金额:
$ 150.5万 - 项目类别:
Identifying and supporting patients with undiagnosed dementia using the EHR Risk of Alzheimer's and Dementia Assessment Rule (eRADAR): a pilot clinical trial
使用 EHR 阿尔茨海默氏症和痴呆症风险评估规则 (eRADAR) 识别和支持未确诊的痴呆症患者:一项试点临床试验
- 批准号:
10665566 - 财政年份:2020
- 资助金额:
$ 150.5万 - 项目类别:
EXTENDING INDEPENDENCE AND QUALITY OF LIFE FOR PEOPLE WITH ALZHEIMER'S DISEASE OR DEMENTIA THROUGH TELEHEALTH PROGRAM DELIVERY
通过远程医疗计划的实施,提高阿尔茨海默病或痴呆症患者的独立性和生活质量
- 批准号:
10019891 - 财政年份:2020
- 资助金额:
$ 150.5万 - 项目类别:
Identifying and supporting patients with undiagnosed dementia using the EHR Risk of Alzheimer's and Dementia Assessment Rule (eRADAR): a pilot clinical trial
使用 EHR 阿尔茨海默氏症和痴呆症风险评估规则 (eRADAR) 识别和支持未确诊的痴呆症患者:一项试点临床试验
- 批准号:
10213652 - 财政年份:2020
- 资助金额:
$ 150.5万 - 项目类别:
Low-cost detection of dementia using electronic health records data: validation and testing of the eRADAR algorithm in a pragmatic, patient-centered trial.
使用电子健康记录数据低成本检测痴呆症:在务实、以患者为中心的试验中验证和测试 eRADAR 算法。
- 批准号:
10266125 - 财政年份:2020
- 资助金额:
$ 150.5万 - 项目类别:
Low-cost detection of dementia using electronic health records data: validation and testing of the eRADAR algorithm in a pragmatic, patient-centered trial.
使用电子健康记录数据低成本检测痴呆症:在务实、以患者为中心的试验中验证和测试 eRADAR 算法。
- 批准号:
10443874 - 财政年份:2020
- 资助金额:
$ 150.5万 - 项目类别:
相似国自然基金
TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
- 批准号:82220108016
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
- 批准号:81800806
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
- 批准号:81700824
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
- 批准号:81670269
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
老年人一体化编码的认知神经机制探索与干预研究:一种减少与老化相关的联结记忆缺陷的新途径
- 批准号:31470998
- 批准年份:2014
- 资助金额:87.0 万元
- 项目类别:面上项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 150.5万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 150.5万 - 项目类别:
The contribution of air pollution to racial and ethnic disparities in Alzheimer’s disease and related dementias: An application of causal inference methods
空气污染对阿尔茨海默病和相关痴呆症的种族和民族差异的影响:因果推理方法的应用
- 批准号:
10642607 - 财政年份:2023
- 资助金额:
$ 150.5万 - 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:
10678789 - 财政年份:2023
- 资助金额:
$ 150.5万 - 项目类别: